Beijing Holley-Cotec Pharmaceuticals Co., Ltd.

30/06/2025

The comprehensive training initiative combines instructional courses with interactive discussion sessions to strengthen pharmaceutical regulatory frameworks for African Union. A big look forward of African Medicines Regulatory Harmonization from AMA.

14/02/2025

Our talented team member Ms. Zouzou from Côte d'Ivoire, has been invited to join us in China for our Annual Meeting! This is a fantastic opportunity to connect with colleagues worldwide, exchange insights, and experience the rich culture of China. We’re proud to celebrate our diverse, collaborative team!

26/01/2025

Delivered First Shipment of DUO-COTECXIN Tablets to The Global Fund to Support Burkina Faso's Fight Against Malaria

http://en.holleycotec.com/news/27.html

31/05/2024

Seminar on the application of Traditional Chinese Medicine in the prevention and treatment of Chronic Diseases.
We welcome colleagues from Latvia, Ethiopia，Jordan，Sri Lanka，Afghanistan，Cuba, Grenada, Malaysia to join us for the discussion.

23/05/2024

Seminário de Controle da Malária dos Países de Língua Portuguesa.
We have trainees from Brazil, Mozambique, Guinea-Bissau and Sao Tome and Principe to attend the seminar for malaria control.

15/05/2024

We actively conducts foreign aid training courses, training more than 1400 medical and health professionals from developing countries, particularly those along the Belt and Road Initiative.

//Care and Aid//
Beijing Holley-Cotec Pharmaceuticals Co., Ltd. is a subsidiary of KPC Pharmaceuticals Inc. under CR Sanjiu, specializes in the production of artemisinin-based Combination Therapy anti-malaria drugs. Prequalified by WHO, the company has established pharmaceutical factories in Africa to register and market its products locally. As of 2023, the company has supplied over 50 million doses of ACT medicines, saving millions of lives globally, especially in developing countries.
The local branch offices have achieved an employee localization rate of 85%, effectively promoting local employment. The company also actively conducts foreign aid training courses, training more than 1400 medical and health professionals from developing countries, particularly those along the Belt and Road Initiative.
Adhering to the aid concept of "Healthy Humanity and Welfare Society," Beijing Holley-Cotec Pharmaceuticals Co., Ltd. actively fulfills its social responsibilities by participating in public welfare activities. The company, together with Chinese medical counterparts, will continue to put into actions to enhance health conditions and give back to society.


#華潤集團

13/05/2024

Team building for the celebration for WHO-PQ of DUO-COTECXIN.

10/10/2023

Our DUO-COTECXIN is WHO-Prequalified!

Product Details WHO Product ID MA177 Status Prequalified INN, dosage form and strength Dihydroartemisinin/Piperaquine phosphate Tablet, Film-coated 40mg/320mg Date of prequalification 10 Oct, 2023 Basis of listing Prequalification - Full Therapeutic area Malaria Type Finished Pharmaceutical Product....

24/04/2023

April 21st, 2023, Sales Team from Super Pharmaceuticals Limited, a subsidiary company of KPC Pharmaceuticals Inc., participated in the ‘World Malaria Day Scientific Colloquium’ held in Kampala, Uganda. The event was organized by Uganda Ministry of Health (MOH) and aimed to raise awareness about malaria and to promote collaboration to combat the disease.

24/04/2023

World Malaria Day：Time to deliver zero malaria: invest, innovate, implement

24/04/2022

World Malaria Day 2022
Together we fight against malaria!

On 4-5 May 2015, officials from Uganda Food and Drug Authority (NDA) conducted a triennial GMP on-site inspection of Zhejiang Holley Nanhu Pharmaceutical Co., LTD.